Novel findings for the development of drug therapy for various liver diseases: Preface

Journal of Pharmacological Sciences

Volumn 115, Issue 3, 2011, Pages 259-262

  Yoneda, Masato ^a   Nakajima, Atsushi ^a   Wada, Koichiro ^b  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Hepatitis C virus (HCV); Liver cirrhosis; Liver disease; Liver failure; Non alcohol fatty liver disease (NAFLD); Non alcohol steatohepatitis (NASH)

Indexed keywords

ADEFOVIR DIPIVOXIL; ALPHA INTERFERON; ALPHA TOCOPHEROL; ASCORBIC ACID; BETAINE; ENTECAVIR; EZETIMIBE; FIBRIC ACID DERIVATIVE; HEPATITIS B VACCINE; HEPATITIS C VACCINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 28B; LAMIVUDINE; LIVER ENZYME; MESSENGER RNA; METFORMIN; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; PEGINTERFERON ALPHA; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2A PLUS RIBAVIRIN; PEGINTERFERON ALPHA2B; PEGINTERFERON ALPHA2B PLUS RIBAVIRIN; PIOGLITAZONE; PROTEINASE INHIBITOR; RIBAVIRIN; ROSIGLITAZONE; TELBIVUDINE; TROGLITAZONE; UNINDEXED DRUG; URSODEOXYCHOLIC ACID;

AUTOLOGOUS BONE MARROW TRANSPLANTATION; DECOMPENSATED LIVER CIRRHOSIS; DRUG RESEARCH; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER TRANSPLANTATION; NONALCOHOLIC FATTY LIVER; PROTEIN EXPRESSION; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79952787511     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.11R01FM     Document Type: Short Survey

References (3)

1. Sugiyama M, Tanaka Y, Nakanishi M, Mizokami M. Novel findings for the development of drug therapy for various liver diseases: Genetic variation in IL-28B is associated with response to the therapy for chronic hepatitis C. J Pharmacol Sci. 2011;115:263-269.
2. Fujita K, Imajo K, Shinohara Y, Nozaki Y, Wada K, Yoneda M, et al. Novel findings for the development of drug therapy for various liver diseases: Liver microsomal triglyceride transfer protein activator may be a possible therapeutic agent in non-alcoholic steatohepatitis. J Pharmacol Sci. 2011;115:270-273.
3. Takami T, Terai S, Sakaida I. Novel findings for the development of drug therapy for various liver diseases: Current state and future prospects for our liver regeneration therapy using autologous bone marrow cells for decompensated liver cirrhosis patients. J Pharmacol Sci. 2011;115:274-278.